To amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.

United States115th CongressHR-3964House of Representatives
Updated: Oct 16, 2017

Summary

Opioid Addiction Prevention Act of 2017 This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to comply with certain requirements when prescribing opioids for the initial treatment of acute pain, such as a limit on the initial supply. An opioid that is approved and prescribed for the treatment of addiction is not subject to the requirements.

Bill texts

Available versions
Introduced (House)View official text

1 version available

All available records shown.

Timeline

Latest companion bill action

S-892: A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.

Introduced in Senate

  1. Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    House of Representatives

  2. Introduced in House

  3. Referred to the Subcommittee on Health.

    House of Representatives

  4. Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

    House of Representatives

All available records shown.